Swiss National Bank buys $426,472,082 stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Swiss National Bank scooped up 186,400 additional shares in UnitedHealth Group Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 2,984,827 shares of UnitedHealth Group Inc which is valued at $426,472,082.UnitedHealth Group Inc makes up approximately 0.67% of Swiss National Bank’s portfolio.

Other Hedge Funds, Including , Crossvault Capital Management reduced its stake in UNH by selling 625 shares or 1.54% in the most recent quarter. The Hedge Fund company now holds 39,870 shares of UNH which is valued at $5,648,782. UnitedHealth Group Inc makes up approx 3.93% of Crossvault Capital Management’s portfolio.Cwm reduced its stake in UNH by selling 19,292 shares or 23.46% in the most recent quarter. The Hedge Fund company now holds 62,948 shares of UNH which is valued at $9,044,998. UnitedHealth Group Inc makes up approx 0.63% of Cwm’s portfolio. Quotient Investors sold out all of its stake in UNH during the most recent quarter. The investment firm sold 5,431 shares of UNH which is valued $768,378.

UnitedHealth Group Inc closed down -0.86 points or -0.60% at $142.13 with 18,46,428 shares getting traded on Monday. Post opening the session at $142.61, the shares hit an intraday low of $141.86 and an intraday high of $143.07 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.